Skip to content
EDIVRO

News built for discoveryGEO · AEO · Agentic search

What is Edivro?Sign inSubmit news / Build profile
News

Explore Edivro

The business of what’s next.

News, company developments and ideas from across the Edivro publishing network.

Explore all stories

The front page

  • Latest storiesThe complete publication bank
  • Company news
  • Latest insights
  • Leadership news

Discover more

  • AI & innovation
  • People & profiles
  • Company features
  • Explore all topics
Stories. Connected.

Explore the Edivro story bank.

Explore all stories →
Explore the story bank →
What is Edivro?Editorial standards
Companies

Explore Edivro

Inside the businesses.

Company stories, brand profiles and announcements, with original dates and source attribution.

Explore company news

Companies & brands

  • Company news
  • Company features
  • Brand stories
  • Brand strategy

Explore business

  • Industry coverage
  • Leadership profiles
  • Business insights
  • Browse by location
Stories. Connected.

Explore the Edivro story bank.

Explore company news →
Explore the story bank →
What is Edivro?Editorial standards
Leaders & Profiles

Explore Edivro

The people behind the story.

Meet founders, executives and professionals through their work and published profiles.

Explore leader profiles

People to know

  • Featured leaders
  • Leadership stories
  • Young entrepreneurs
  • Newsmakers

Ideas & work

  • Leadership news
  • Workplace & culture
  • Company stories
  • Browse public profilesPeople behind the coverage
Stories. Connected.

Explore the Edivro story bank.

Explore leader profiles →
Explore the story bank →
What is Edivro?Editorial standards
Industries

Explore Edivro

A wider view of business.

Follow developments across sectors, from artificial intelligence to healthcare and real estate.

Explore all industries

Industry coverage

  • Artificial intelligence
  • Business
  • Real estate
  • Healthcare

More sectors

  • Manufacturing
  • Education
  • Fintech
  • All sectors & topics
Stories. Connected.

Explore the Edivro story bank.

Explore all industries →
Explore the story bank →
What is Edivro?Editorial standards
AI & Tech

Explore Edivro

Ideas changing the way we work.

Artificial intelligence, enterprise technology and the businesses building what comes next.

Explore AI coverage

AI & technology

  • Artificial intelligence
  • Technology stories
  • Enterprise AI & SaaS
  • Fintech & payments

News & insight

  • AI news
  • Industry insights
  • Company announcements
  • Research & ideas
Stories. Connected.

Explore the Edivro story bank.

Explore AI coverage →
Explore the story bank →
What is Edivro?Editorial standards
Press Room

Explore Edivro

Announcements. In context.

Find business announcements, company news and clearly labelled press releases.

Explore the Press Room

Read announcements

  • Company news & releasesAnnouncements from named issuers
  • Company news
  • Latest published stories
  • Browse industries

News by subject

  • Funding & investment
  • Appointments
  • Products & launches
  • Partnerships
Stories. Connected.

Explore the Edivro story bank.

Explore the Press Room →
Explore the story bank →
What is Edivro?Editorial standards
Work with Edivro

Create on Edivro

Choose how you work with Edivro.

Publishing for individuals and companies, client orders for agencies, and wider communications programmes for businesses.

Explore the three routes

Who you are

  • Individuals and companiesProfiles, stories and press releases
  • AgenciesPublishing for authorised clients
  • Corporate and businessPR, content, discovery and campaigns
  • Services & pricingCurrent per-article prices

Publishing tools

  • Build your profile
  • Submit your news
  • Edivro AI
  • How publishing works
Your next story.

Work with Edivro

Choose the route that fits your work.

Explore services
Explore the story bank →
What is Edivro?Editorial standards
Latest storiesCompany newsLeader profilesArtificial intelligence

Explore Edivro

News, companies and the people behind them.

News

Explore Edivro

The business of what’s next.

News, company developments and ideas from across the Edivro publishing network.

Explore all stories

The front page

  • Latest storiesThe complete publication bank
  • Company news
  • Latest insights
  • Leadership news

Discover more

  • AI & innovation
  • People & profiles
  • Company features
  • Explore all topics
Stories. Connected.

Explore the Edivro story bank.

Explore all stories →
Explore the story bank →
What is Edivro?Editorial standards
Companies

Explore Edivro

Inside the businesses.

Company stories, brand profiles and announcements, with original dates and source attribution.

Explore company news

Companies & brands

  • Company news
  • Company features
  • Brand stories
  • Brand strategy

Explore business

  • Industry coverage
  • Leadership profiles
  • Business insights
  • Browse by location
Stories. Connected.

Explore the Edivro story bank.

Explore company news →
Explore the story bank →
What is Edivro?Editorial standards
Leaders & Profiles

Explore Edivro

The people behind the story.

Meet founders, executives and professionals through their work and published profiles.

Explore leader profiles

People to know

  • Featured leaders
  • Leadership stories
  • Young entrepreneurs
  • Newsmakers

Ideas & work

  • Leadership news
  • Workplace & culture
  • Company stories
  • Browse public profilesPeople behind the coverage
Stories. Connected.

Explore the Edivro story bank.

Explore leader profiles →
Explore the story bank →
What is Edivro?Editorial standards
Industries

Explore Edivro

A wider view of business.

Follow developments across sectors, from artificial intelligence to healthcare and real estate.

Explore all industries

Industry coverage

  • Artificial intelligence
  • Business
  • Real estate
  • Healthcare

More sectors

  • Manufacturing
  • Education
  • Fintech
  • All sectors & topics
Stories. Connected.

Explore the Edivro story bank.

Explore all industries →
Explore the story bank →
What is Edivro?Editorial standards
AI & Tech

Explore Edivro

Ideas changing the way we work.

Artificial intelligence, enterprise technology and the businesses building what comes next.

Explore AI coverage

AI & technology

  • Artificial intelligence
  • Technology stories
  • Enterprise AI & SaaS
  • Fintech & payments

News & insight

  • AI news
  • Industry insights
  • Company announcements
  • Research & ideas
Stories. Connected.

Explore the Edivro story bank.

Explore AI coverage →
Explore the story bank →
What is Edivro?Editorial standards
Press Room

Explore Edivro

Announcements. In context.

Find business announcements, company news and clearly labelled press releases.

Explore the Press Room

Read announcements

  • Company news & releasesAnnouncements from named issuers
  • Company news
  • Latest published stories
  • Browse industries

News by subject

  • Funding & investment
  • Appointments
  • Products & launches
  • Partnerships
Stories. Connected.

Explore the Edivro story bank.

Explore the Press Room →
Explore the story bank →
What is Edivro?Editorial standards
Work with Edivro

Create on Edivro

Choose how you work with Edivro.

Publishing for individuals and companies, client orders for agencies, and wider communications programmes for businesses.

Explore the three routes

Who you are

  • Individuals and companiesProfiles, stories and press releases
  • AgenciesPublishing for authorised clients
  • Corporate and businessPR, content, discovery and campaigns
  • Services & pricingCurrent per-article prices

Publishing tools

  • Build your profile
  • Submit your news
  • Edivro AI
  • How publishing works
Your next story.

Work with Edivro

Choose the route that fits your work.

Explore services
Explore the story bank →
What is Edivro?Editorial standards

Your publishing workspace

Build a profile. Prepare your story. Manage orders and billing.

Sign in / create account
What is Edivro?How it worksServices & pricing

Search Edivro

Browse full results →
  1. EDIVRO/
  2. Stories
EDIVRO EditorialHealthcare

Mankind Pharma agrees €48 million investment in Armed Cell Therapeutics

The proposed 70% stake would give Mankind an interest in a biotechnology business developing next-generation CAR-T candidates.

By Edivro Company News
India · 27 Oct 2026 · 1 min read
Share story ↓
Add as a Preferred Source on GoogleFind Edivro on Google News
Mankind Pharma agrees €48 million investment in Armed Cell Therapeutics — Edivro editorial illustration
EDIVROEditorial illustration

Edivro Company News · Original attributed summary. Source announcement: 2026-10-15.

At a glance

  • Mankind Pharma has entered a definitive agreement to invest €48 million for a 70% stake in Armed Cell Therapeutics.
  • The biotechnology business is developing next-generation CAR-T candidates, with lead programmes focused on non-Hodgkin lymphoma and small cell lung cancer.

Mankind Pharma has entered a definitive agreement to invest €48 million for a 70% stake in Armed Cell Therapeutics. The transaction is being undertaken through Mankind Pharma (Netherlands) B.V., according to the company’s 15 October announcement.

What does Armed Cell Therapeutics develop?

The biotechnology business is developing next-generation CAR-T candidates, with lead programmes focused on non-Hodgkin lymphoma and small cell lung cancer. Mankind describes research and development teams in the US and Europe, alongside work on in-vivo CAR-T cell generation.

The announcement names Paul Stoffels as chair of Armed Cell Therapeutics and John Mellors as chief scientific officer. It places the investment within Mankind’s stated strategy of building an innovation-led pharmaceutical business.

What does the agreement establish?

The release establishes an agreed investment and intended majority stake. It does not present the transaction as proof that a therapy is approved, available to patients or clinically effective. Development candidates, clinical evidence and regulatory authorisation are separate matters.

Mankind says the investment is intended to build access to scientific platforms and a pipeline of potential therapies. The commercial outcome depends on subsequent development and other conditions described in the company’s forward-looking statements. No treatment recommendation follows from this acquisition announcement.

Questions about this story

These answers summarise the article and refer to its original reporting period.

What does Armed Cell Therapeutics develop?

The biotechnology business is developing next-generation CAR-T candidates, with lead programmes focused on non-Hodgkin lymphoma and small cell lung cancer. Mankind describes research and development teams in the US and Europe, alongside work on in-vivo CAR-T cell generation.

What does the agreement establish?

The release establishes an agreed investment and intended majority stake. It does not present the transaction as proof that a therapy is approved, available to patients or clinically effective. Development candidates, clinical evidence and regulatory authorisation are separate matters.

Sources and links

  • mankindpharma.com — https://www.mankindpharma.com/media/press-release/mankind-pharma-to-acquire-majority-stake-in-armed-cell-therapeutics-marking-strategic-entry-into-next-generation-car-t-therapies/
Request a correctionEditorial standards
HealthcareCompany NewsEdivro Daily 2026 10 27India

Publisher

Edivro Company News

Share this story

LinkedInFacebookXWhatsAppTelegramRedditPinterestThreadsBlueskyEmail

Healthcare

Related stories

Alisha Moopen: Leading the Next Era of Gulf Healthcare — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

founder story

Alisha Moopen: Leading the Next Era of Gulf Healthcare

From expanding hospital networks to digital health, AI-enabled care and a growing Saudi footprint, Alisha Moopen is helping transform Aster DM Healthcare from a traditional provider into a connected healthcare ecosystem for the GCC.

4 Sept 2026

EDIVRO News Profile feature from the imported archive. Original publication dates retained.

Akbar Moideen Thumbay: Building the Next Generation of UAE Healthcare — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

founder story

Akbar Moideen Thumbay: Building the Next Generation of UAE Healthcare

At the intersection of hospitals, medical education, research and patient experience, Akbar Moideen Thumbay is helping shape the next chapter of one of the UAE’s most distinctive healthcare ecosystems.

4 Sept 2026

EDIVRO News Profile feature from the imported archive. Original publication dates retained.

The Leadership Test in Deciding Which Customers to Stop Serving — Edivro editorial illustrationEDIVROEditorial illustration
EDIVRO News Profile

story

The Leadership Test in Deciding Which Customers to Stop Serving

A strategy becomes easier to assess when a company explains which business it will stop pursuing. The difficult work begins with the obligations that remain.

27 Oct 2026

Pulled from WCRC. Original publication date retained.

Original publication dates and source disclosures are retained. New submissions are reviewed before publication.

EDIVRO

Edivro publishes business news, company and leadership profiles, and industry analysis. Our publishing approach combines SEO, GEO and AEO with clear headlines, named sources and useful answers for readers and AI research agents.

Explore publishing on Edivro
Add as a Preferred Source on GoogleFind Edivro on Google News

About Edivro

  • About us
  • How it works
  • Editorial standards
  • Corrections & contact

Publish with Edivro

  • For creators
  • For agencies
  • For businesses
  • Pricing

Learn about discovery

  • Publishing for search and AI
  • SEO vs GEO vs AEO
  • Agentic search
  • Company announcements
  • Search discovery
  • Measure AI visibility

Explore Edivro

  • Latest stories
  • Industries
  • Company profiles
  • Leadership profiles
  • Press Room

© 2026 EDIVRO. All rights reserved.

Sign in / My StudioTerms & refundsPrivacySubscribe via RSS

Press releases are submitted content and are labelled as such.